| Description | The anti-influenza A virus mAb exhibited the strongest H7 HA binding capacity. It effectively prevented influenza A H7N9 viral infection when used at antibody concentrations ranging from 200 to 25 μg/ml. |
| Clonality | Monoclonal |
| Host Species | Human |
| Target Species | Influenza A virus (IAV) |
| Isotype | IgG1 |
| Expression Species | HEK293F or CHO cell line |
| Conjugation | Unconjugated |
| Purity | >95% |
| Endotoxin | <1 EU/mg |
| Form | Liquid |
| Purification | Protein A purified |
| Sterility | 0.2 μM filtered |
| Formulation | PBS, pH 7.4 |
| Preservation | No preservatives |
| Stabilizer | No stabilizers |
| Storage | Store at 4°C within one or two weeks. Store at -20°C for long term. Avoid repeated freeze/thaw cycles. Refer to the COA file for specifics. |
| Application | ELISA; Neut |
| Application Notes | Function assay: The concentrations ranging from 200 to 25 μg/ml to prevent influenza A H7N9 viral infection. |
| ELISA | Enzyme-Linked Immunosorbent Assay Protocol |
| WB | Western Blot Protocol |
| FC | Flow Cytometry Protocol |
| Target | IAV H7N9 |
| Alternative Name | Influenza A virus H7N9; H7N9; Influenza A virus |
| Research Area | Microbiology |
